Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Selling, general, and administrative expenses
3Y CAGR
+181.0%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
22.2x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $30.31M | +37.0% |
| 2024 | $22.12M | +174.2% |
| 2023 | $8.07M | +490.7% |
| 2022 | $1.37M | - |